BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 31856786)

  • 1. Validation of the King's Brief Interstitial Lung Disease questionnaire in Idiopathic Pulmonary Fibrosis.
    Prior TS; Hilberg O; Shaker SB; Davidsen JR; Hoyer N; Birring SS; Bendstrup E
    BMC Pulm Med; 2019 Dec; 19(1):255. PubMed ID: 31856786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the IPF-specific version of St. George's Respiratory Questionnaire.
    Prior TS; Hoyer N; Shaker SB; Davidsen JR; Yorke J; Hilberg O; Bendstrup E
    Respir Res; 2019 Aug; 20(1):199. PubMed ID: 31462235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responsiveness and minimal clinically important difference of SGRQ-I and K-BILD in idiopathic pulmonary fibrosis.
    Prior TS; Hoyer N; Hilberg O; Shaker SB; Davidsen JR; Bendstrup E
    Respir Res; 2020 Apr; 21(1):91. PubMed ID: 32316976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translation and validation of the King's Brief Interstitial Lung Disease (K-BILD) questionnaire in French, Italian, Swedish, and Dutch.
    Wapenaar M; Patel AS; Birring SS; Domburg RTV; Bakker EW; Vindigni V; Sköld CM; Cottin V; Vancheri C; Wijsenbeek MS
    Chron Respir Dis; 2017 May; 14(2):140-150. PubMed ID: 28019103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development and validation of the King's Brief Interstitial Lung Disease (K-BILD) health status questionnaire.
    Patel AS; Siegert RJ; Brignall K; Gordon P; Steer S; Desai SR; Maher TM; Renzoni EA; Wells AU; Higginson IJ; Birring SS
    Thorax; 2012 Sep; 67(9):804-10. PubMed ID: 22555278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. R-scale for pulmonary fibrosis: a simple, visual tool for the assessment of health-related quality of life.
    Scallan C; Strand L; Hayes J; Kadura S; Collins B; Ho L; Spada C; Canestaro W; Kolb M; Raghu G
    Eur Respir J; 2022 Jan; 59(1):. PubMed ID: 34112729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The psychometric properties of the King's Brief Interstitial Lung Disease questionnaire and thresholds for meaningful treatment response in patients with progressive fibrosing interstitial lung diseases.
    Birring SS; Bushnell DM; Baldwin M; Mueller H; Male N; Rohr KB; Inoue Y
    Eur Respir J; 2022 Jun; 59(6):. PubMed ID: 34764181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life assessment in interstitial lung diseases:a comparison of the disease-specific K-BILD with the generic EQ-5D-5L.
    Szentes BL; Kreuter M; Bahmer T; Birring SS; Claussen M; Waelscher J; Leidl R; Schwarzkopf L
    Respir Res; 2018 May; 19(1):101. PubMed ID: 29801506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic characteristics associated with slow gait speed in idiopathic pulmonary fibrosis.
    Nolan CM; Maddocks M; Maher TM; Canavan JL; Jones SE; Barker RE; Patel S; Jacob J; Cullinan P; Man WD
    Respirology; 2018 May; 23(5):498-506. PubMed ID: 29139195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The minimal important difference of the King's Brief Interstitial Lung Disease Questionnaire (K-BILD) and forced vital capacity in interstitial lung disease.
    Patel AS; Siegert RJ; Keir GJ; Bajwah S; Barker RD; Maher TM; Renzoni EA; Wells AU; Higginson IJ; Birring SS
    Respir Med; 2013 Sep; 107(9):1438-43. PubMed ID: 23867809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychometric properties of patient reported outcome measures in idiopathic pulmonary fibrosis.
    Kim JW; Clark A; Birring SS; Atkins C; Whyte M; Wilson AM
    Chron Respir Dis; 2021; 18():14799731211033925. PubMed ID: 34609156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of a derived version of the IPF-specific Saint George's Respiratory Questionnaire.
    Prior TS; Hoyer N; Shaker SB; Davidsen JR; Hilberg O; Patel H; Bendstrup E
    Respir Res; 2021 Oct; 22(1):259. PubMed ID: 34610840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ILD-specific health-related quality of life in systemic sclerosis-associated ILD compared with IPF.
    Durheim MT; Hoffmann-Vold AM; Eagan TM; Hovden AO; Lund MB; Bjerke G; Birring SS; Jonassen TM; Johansen OE; Sjåheim T
    BMJ Open Respir Res; 2020 Jun; 7(1):. PubMed ID: 32576559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the Brazilian Portuguese version of the University of California San Diego Shortness of Breath Questionnaire in patients with interstitial lung disease.
    Silva H; Mantoani LC; Zamboti CL; Aguiar WF; Ries AL; Gonçalves AFL; Silva TGD; Ribeiro M; Pitta F; Camillo CA
    J Bras Pneumol; 2021; 47(6):e20210172. PubMed ID: 34932719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A role for cardiopulmonary exercise testing in detecting physiological changes underlying health status in Idiopathic pulmonary fibrosis: a feasibility study.
    Davis R; Dixon C; Millar AB; Maskell NA; Barratt SL
    BMC Pulm Med; 2021 May; 21(1):147. PubMed ID: 33952224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translation to Spanish and Validation of the Specific Saint George's Questionnaire for Idiopathic Pulmonary Fibrosis.
    Capparelli I; Fernandez M; Saadia Otero M; Steimberg J; Brassesco M; Campobasso A; Palacios S; Caro F; Alberti ML; Rabinovich RA; Paulin F
    Arch Bronconeumol (Engl Ed); 2018 Feb; 54(2):68-73. PubMed ID: 29102341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a respiratory symptom diary for clinical studies of idiopathic pulmonary fibrosis.
    Bacci ED; O'Quinn S; Leidy NK; Murray L; Vernon M
    Respir Med; 2018 Jan; 134():130-138. PubMed ID: 29413500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COPD Assessment Test for measurement of health status in patients with idiopathic pulmonary fibrosis: A cross-sectional study.
    Matsuda T; Taniguchi H; Ando M; Kondoh Y; Kimura T; Kataoka K; Sakamoto K; Suzuki A; Furukawa T; Hasegawa Y
    Respirology; 2017 May; 22(4):721-727. PubMed ID: 27859913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reliability and validity of Chinese version of a tool to assess the quality of life in idiopathic pulmonary fibrosis in patients with interstitial lung disease.
    Pan RL; Swigris JJ; Zhao YW; Guo AM; Wu Q; Li SJ
    Int J Nurs Sci; 2019 Jan; 6(1):38-42. PubMed ID: 31406867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender differences at presentation of idiopathic pulmonary fibrosis in Sweden.
    Kalafatis D; Gao J; Pesonen I; Carlson L; Sköld CM; Ferrara G
    BMC Pulm Med; 2019 Nov; 19(1):222. PubMed ID: 31771560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.